Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Surg Endosc ; 22(10): 2178-83, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18622566

RESUMO

BACKGROUND: Hybrid simulators provide objective metrics for laparoscopic task performance. This study aimed to evaluate the correlation between hybrid simulator-generated metrics and content-valid outcome measures. METHODS: Residents underwent training with a previously validated 5-task simulation model (5-TSM). The resident tasks included vessel clipping and dividing, lesion excision, loop appendectomy, mesh placement with tacks, and suture perforation with intracorporeal knot tying. After training, the residents were tested using the open module of a hybrid simulator (ProMIS) with previously validated passing scores. Content validity was defined as the extent to which outcome measures departed from clinical reality. Content-valid outcome measures (accuracy error, knot slippage, leak, operating time, tissue damage) were evaluated by two blinded raters. The hybrid simulator-generated metrics were path length and smoothness of movements. Values are given as means (standard deviation is not shown). RESULTS: Over 23 months, 20 residents underwent training with 5-TSM. Respectively, for tasks 1 to 5, the path length was 3,895, 3,472, 4,620, 2,408, and 9,089 mm; the smoothness (jerk) was 346, 455, 549, 264, and 910 cm/sec3; the accuracy error was 0.45, 2.20, 0.55, 0.87, and 0.20 mm; and the knot slippage was 5%. There were no leaks. The operating time, respectively, was 54, 61, 135, 43, and 130 s, and the tissue damage was 0, 0.28, 0, 0.8, and 0 mm. The interrater reliability was more than 0.80 for all the outcome measures except accuracy error (k=0.52). There was correlation between path length and operating time (Spearman rho, 0.537-0.709; p<0.05) for all the tasks. There was no correlation between path length and accuracy error, knot slippage, leak, and tissue damage. No correlation was found between smoothness and any of the outcome measures for any of the tasks except operating time (Spearman rho, 0.762-0.958; p<0.05). CONCLUSIONS: Although an expected strong correlation was observed between hybrid simulator-generated metrics and operating time, this study showed no correlation between simulator-generated metrics and other content-valid outcome measures.


Assuntos
Competência Clínica , Simulação por Computador , Internato e Residência , Laparoscopia , Análise e Desempenho de Tarefas , Adulto , Feminino , Humanos , Masculino , Estudos Prospectivos
2.
Ann Vasc Surg ; 22(5): 643-8, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18562162

RESUMO

The optimal dosing strategy for perioperative beta-blockers to safely achieve recommended target heart rates (HRs) by current guidelines is not well defined. An HR-titrated perioperative beta-blocker dosing regimen versus a fixed-dose regimen was assessed by clinical outcomes, postoperative heart rate, and beta-blocker-related complications. Patients (n = 64) scheduled to undergo moderate- to high-risk vascular surgery and without contraindications to beta-blockade were randomized to either a fixed-dose or HR-titrated beta-blocker dosing schedule. Clinical outcomes and HRs were followed immediately preoperatively to 24 hr postoperatively. A difference in mean HR between the two dosing arms was significant immediately postoperatively (70.1 vs. 58.2 bpm for fixed dose and HR-titrated arms, respectively; p = 0.012) but at no other time points. However, the HR-titrated strategy led to a significant reduction in the percentage of HR measurements >80 bpm (34.5% vs. 16.1%, p < 0.001) and to a significant reduction in absolute HR change (17.5 vs. 22.5 bpm, p = 0.034). There were no significant differences in the occurrence of asymptomatic hypotension between the two study arms, and no beta-blocker-related adverse events occurred in either study arm. An aggressive, HR-titrated perioperative beta-blocker dosing strategy was associated with more consistent maintenance of postoperative HRs within the range recommended by current guidelines and did not result in increased drug-related adverse events. The question of what is the best perioperative beta-blocker dosing regimen warrants further evaluation in a large-scale clinical trial.


Assuntos
Antagonistas Adrenérgicos beta/administração & dosagem , Fármacos Cardiovasculares/administração & dosagem , Doenças Cardiovasculares/prevenção & controle , Frequência Cardíaca/efeitos dos fármacos , Procedimentos Cirúrgicos Vasculares/efeitos adversos , Antagonistas Adrenérgicos beta/efeitos adversos , Idoso , Fármacos Cardiovasculares/efeitos adversos , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/fisiopatologia , Esquema de Medicação , Feminino , Humanos , Masculino , Assistência Perioperatória , Guias de Prática Clínica como Assunto , Fatores de Tempo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA